丸美生物
(603983)
| 流通市值：134.50亿 | | | 总市值：134.50亿 |
| 流通股本：4.01亿 | | | 总股本：4.01亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,591,921,263.21 | 1,672,805,988.45 | 1,694,566,806 | 2,032,128,563.24 |
| 交易性金融资产 | 412,622,657.55 | 390,511,396.59 | 390,113,115.77 | 395,698,036.38 |
| 应收票据及应收账款 | 20,406,964.01 | 25,466,199.58 | 57,054,102.2 | 44,998,454.03 |
| 应收账款 | 20,406,964.01 | 25,466,199.58 | 57,054,102.2 | 44,998,454.03 |
| 应收款项融资 | 1,691,250 | 922,500 | 1,430,000 | 1,430,000 |
| 预付款项 | 96,371,057.48 | 81,540,610.04 | 99,519,852.88 | 41,362,251.1 |
| 其他应收款合计 | 12,458,279.65 | 12,164,012.69 | 12,025,885.98 | 11,572,745.01 |
| 存货 | 281,372,130.76 | 241,104,451.2 | 243,011,003.87 | 219,658,341.31 |
| 一年内到期的非流动资产 | 53,354,794.52 | - | - | 44,084,931.52 |
| 其他流动资产 | 123,883,379.16 | 135,101,028.4 | 143,297,594.63 | 163,469,303.49 |
| 流动资产合计 | 2,594,081,776.34 | 2,559,616,186.95 | 2,641,018,361.33 | 2,954,402,626.08 |
| 非流动资产: | | | | |
| 长期应收款 | - | 638,711 | 953,300 | 953,300 |
| 长期股权投资 | 226,223,585.42 | 180,465,729.74 | 180,655,821.89 | 165,655,582.9 |
| 投资性房地产 | 211,932,514.54 | 186,457,039.67 | 3,199,812.73 | 3,278,251.01 |
| 固定资产 | 996,677,200.89 | 956,591,209.69 | 474,447,372.19 | 475,595,007.8 |
| 在建工程 | 19,068,806.7 | 27,594,774.41 | 617,601,656.37 | 603,055,737.06 |
| 使用权资产 | 2,724,606.9 | 1,145,318.24 | 1,172,766.72 | 3,148,264.16 |
| 无形资产 | 688,488,832.43 | 690,215,398.29 | 694,683,381.32 | 699,162,245.19 |
| 长期待摊费用 | 7,982,034.64 | 12,310,027.51 | 16,615,742.17 | 1,741,298.16 |
| 递延所得税资产 | 90,408,654.07 | 85,973,531.71 | 85,611,942.55 | 91,846,317.66 |
| 其他非流动资产 | 9,034,847.18 | 57,337,089.55 | 63,829,056.51 | 63,725,464.79 |
| 非流动资产合计 | 2,252,541,082.77 | 2,198,728,829.81 | 2,138,770,852.45 | 2,108,161,468.73 |
| 资产总计 | 4,846,622,859.11 | 4,758,345,016.76 | 4,779,789,213.78 | 5,062,564,094.81 |
| 流动负债: | | | | |
| 短期借款 | 572,990,000 | 547,990,000 | 510,000,000 | 790,104,166.67 |
| 应付票据及应付账款 | 210,968,699.28 | 368,953,166.69 | 285,207,054.4 | 359,240,825.46 |
| 应付账款 | 210,968,699.28 | 368,953,166.69 | 285,207,054.4 | 359,240,825.46 |
| 合同负债 | 176,365,461.37 | 177,109,148.25 | 189,806,404.62 | 195,122,115.12 |
| 应付职工薪酬 | 26,152,975.51 | 17,161,496.55 | 15,585,434.63 | 27,125,286.63 |
| 应交税费 | 29,643,306.16 | 41,315,985.78 | 51,784,896.89 | 50,691,869.86 |
| 其他应付款合计 | 403,504,216.16 | 152,300,186.85 | 113,537,751.89 | 158,013,863.69 |
| 应付股利 | 100,250,000 | - | - | - |
| 一年内到期的非流动负债 | 1,059,788.03 | 788,427.69 | 996,327.69 | 2,362,855.76 |
| 其他流动负债 | 16,147,822.46 | 17,044,655.63 | 13,950,348.99 | 13,879,155.67 |
| 流动负债合计 | 1,436,832,268.97 | 1,322,663,067.44 | 1,180,868,219.11 | 1,596,540,138.86 |
| 非流动负债: | | | | |
| 租赁负债 | 1,925,368.01 | 419,791.07 | 507,766.76 | 1,504,100.74 |
| 预计负债 | - | - | 360,000 | 360,000 |
| 递延收益 | 4,752,289.43 | 4,964,251.55 | 5,176,213.67 | 5,393,246.26 |
| 递延所得税负债 | 11,826,927.02 | 10,737,799.86 | 12,091,823.4 | 12,263,111.19 |
| 非流动负债合计 | 18,504,584.46 | 16,121,842.48 | 18,135,803.83 | 19,520,458.19 |
| 负债合计 | 1,455,336,853.43 | 1,338,784,909.92 | 1,199,004,022.94 | 1,616,060,597.05 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 401,000,000 | 401,000,000 | 401,000,000 | 401,000,000 |
| 资本公积 | 760,997,417.99 | 760,997,417.99 | 760,997,417.99 | 760,997,417.99 |
| 其他综合收益 | -1,781,619.5 | -1,820,648.73 | -1,768,129.75 | -1,708,532.4 |
| 盈余公积 | 200,909,800 | 200,909,800 | 200,909,800 | 200,909,800 |
| 未分配利润 | 1,962,350,461.48 | 1,993,118,851.83 | 2,154,253,296.59 | 2,019,208,207.26 |
| 归属于母公司股东权益合计 | 3,323,476,059.97 | 3,354,205,421.09 | 3,515,392,384.83 | 3,380,406,892.85 |
| 少数股东权益 | 67,809,945.71 | 65,354,685.75 | 65,392,806.01 | 66,096,604.91 |
| 股东权益合计 | 3,391,286,005.68 | 3,419,560,106.84 | 3,580,785,190.84 | 3,446,503,497.76 |
| 负债和股东权益合计 | 4,846,622,859.11 | 4,758,345,016.76 | 4,779,789,213.78 | 5,062,564,094.81 |
| 公告日期 | 2025-10-31 | 2025-08-23 | 2025-04-26 | 2025-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |